hemay005
Showing 1 - 8 of 8
Behçet's Disease Trial in Beijing (Hemay005, Placebo)
Recruiting
- Behçet's Disease
- Hemay005
- Placebo
-
Beijing, Beijing, ChinaPeking University People's Hospital
Nov 17, 2023
Hemay005, Atopic Dermatitis Trial in Shijiazhuang (Hemay005)
Recruiting
- Hemay005, Atopic Dermatitis
- Hemay005
-
Shijiazhuang, Hebei, ChinaFirst Hospital of Hebei Medical University
Mar 14, 2023
Psoriasis Trial in Guangzhou (Hemay005)
Active, not recruiting
- Psoriasis
- Hemay005
-
Guangzhou, ChinaSun Yat-sen Memorial Hospital of Sun Yat-sen University
Oct 12, 2021
Active Ankylosing Spondylitis Trial in China (Hemay005)
Not yet recruiting
- Active Ankylosing Spondylitis
- Hemay005
-
Hefei, Anhui, China
- +10 more
Jun 2, 2022
Behçet Disease Trial in China (Hemay005, Placebo)
Terminated
- Behçet Disease
- Hemay005
- Placebo
-
Bengbu, Anhui, China
- +30 more
Jun 15, 2022
Psoriasis Trial in Beijing (Hemay005, Placebo)
Unknown status
- Psoriasis
- Hemay005
- Placebo
-
Beijing, ChinaPeking Union Medical College Hospital
Sep 29, 2018
Psoriasis Trial (Hemay005)
Unknown status
- Psoriasis
- Hemay005
- (no location specified)
Jul 3, 2018
Psoriasis Trial in Beijin (Hemay005, Placebos)
Completed
- Psoriasis
- Hemay005
- Placebos
-
Beijin, ChinaPeking Union Medical College Hospital
Jun 17, 2018